Z2's direct consultancy focus is cell line development and upstream process development within the biologics CMC pathway. Biologics programmes rarely stop at the upstream boundary, though – so Z2 draws on a panel of experienced consultants who bring broader bioprocess development expertise.
This enables wider scientific and cross-functional perspectives to be integrated into a programme where required, without losing the focus and accountability of a single lead consultant.
Beyond cell line & upstream
Where a programme needs wider input, the panel covers the interfaces that most often determine whether an upstream process succeeds downstream and at scale.
Downstream processing
Purification strategy and the upstream/downstream interface – so titre gains upstream translate into recoverable product.
Analytical & bioanalytical
Product quality and characterisation input that underpins clone selection, process comparability and CMC documentation.
Manufacturing interfaces
Perspective on GMP manufacture, receiving sites and CDMOs as a process moves towards manufacturing readiness.
AI/ML consultants
Where predictive or hybrid modelling is the right answer, specialist modellers are engaged and directed by Z2's process understanding.
How the panel works with you
- A single point of contact – the Z2 lead consultant
- Specialists brought in only where the programme needs them
- Cross-functional discussions grounded in cell line and upstream reality
- Joined-up advice across the biologics development pathway
If your question sits outside cell line and upstream development, get in touch – we will tell you honestly whether it is a fit for Z2 and the panel.
